Collagen Implant PMA “Approvable” Letter Facilitates 2004 Launch – Artes
This article was originally published in The Gray Sheet
Executive Summary
Artes Medical maintains that within six months FDA will inspect a collagen manufacturing facility under development, permitting U.S. launch of facial wrinkle treatment Artefill later this year
You may also be interested in...
Venture Capital Spending Up For Wide Range Of Devices
Venture capital investment in medical devices during the first quarter of 2006 was up 63% to $690 mil. compared with the same period in 2005, a new report says
Venture Capital Spending Up For Wide Range Of Devices
Venture capital investment in medical devices during the first quarter of 2006 was up 63% to $690 mil. compared with the same period in 2005, a new report says
BioForm Medical Does Not Expect Any Wrinkles In Upcoming Submission
BioForm Medical says it plans to submit a PMA for a new product to fill face wrinkles by the end of November